Quantcast
Channel: cafepharma - JAK3 inhibitors
Browsing all 3 articles
Browse latest View live

Phase 2 Data for Selective Oral JAK3 Inhibitor VX-509 Show Significant...

Phase 2 Data for Selective Oral JAK3 Inhibitor VX-509 Show Significant Improvements in Signs and Symptoms of Rheumatoid Arthritis Yahoo/BusinessWire

View Article



Outlooks for Pfizer, Arena and Onyx Following Busy May

Outlooks for Pfizer, Arena and Onyx Following Busy May TheStreet.com

View Article

Taxpayer Funds, A Pfizer Drug And Big Profits

Taxpayer Funds, A Pfizer Drug And Big Profits Pharmalot

View Article
Browsing all 3 articles
Browse latest View live




Latest Images